A Trial of Hydroxynidone Capsules in Single-dose Administration for Patients With Renal Insufficiency
Clinical trial NCT07262333 · RECRUITING
Trial details
- NCT number
- NCT07262333
- Sponsor
- Beijing Continent Pharmaceutical Co, Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-25
- Primary completion
- 2026-12-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.